Celldex Therapeutics to Present at 10th Annual SVB Leerink Global Healthcare Conference
Celldex Therapeutics, Inc. (Nasdaq:CLDX) today announced that the
Company will participate in a fireside chat at the 10th Annual SVB
Leerink Global Healthcare Conference on Wednesday, February 24,
2021 at 2:20 p.m. ET.
A webcast of the presentation will be available on the "Events
& Presentations" page of the "Investors & Media" section of
the Celldex website. A replay will be available for fourteen days
following the event.
About Celldex Therapeutics, Inc.Celldex is a
clinical stage biotechnology company dedicated to developing
monoclonal and bispecific antibodies that address devastating
diseases for which available treatments are inadequate. Our
pipeline includes antibody-based therapeutics which have the
ability to engage the human immune system and/or directly effect
critical pathways to improve the lives of patients with
inflammatory diseases and many forms of cancer.
Company ContactSarah CavanaughSenior Vice
President, Corporate Affairs & AdministrationCelldex
Therapeutics, Inc.(781) firstname.lastname@example.org